Why the study?
Does flecainide suppress bidirectional ventricular tachycardia in a patient with Andersen-Tawil syndrome?
Population
1 young woman with sustained bidirectional ventricular tachycardia and Andersen-Tawil syndrome.
Design
Case_report
Follow-up
4 years
Authors
Loading...
Flecainide may terminate BVT in Andersen-Tawil syndrome; hypothesis-generating and requires prospective validation before clinical adoption.
Does flecainide suppress bidirectional ventricular tachycardia in a patient with Andersen-Tawil syndrome?
Flecainide may be an effective treatment for suppressing bidirectional ventricular tachycardia and reversing associated tachycardia-induced cardiomyopathy in patients with Andersen-Tawil syndrome.
Pellizzón et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: